🚀 VC round data is live in beta, check it out!
NeuroOne Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for NeuroOne Medical and similar public comparables like CytoSorbents, Pulsenmore, Implanet, Vivos and more.
NeuroOne Medical Overview
About NeuroOne Medical
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.
Founded
2009
HQ
Employees
18
Website
Financials (LTM)
EV
$34M
NeuroOne Medical Financials
NeuroOne Medical reported last 12-month revenue of $10M.
In the same LTM period, NeuroOne Medical generated $6M in gross profit and had net loss of ($5M).
Revenue (LTM)
NeuroOne Medical P&L
In the most recent fiscal year, NeuroOne Medical reported revenue of $9M and EBITDA of ($3M).
NeuroOne Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $10M | XXX | $9M | XXX | XXX | XXX |
| Gross Profit | $6M | XXX | $5M | XXX | XXX | XXX |
| Gross Margin | 55% | XXX | 57% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($3M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (33%) | XXX | XXX | XXX |
| EBIT Margin | (57%) | XXX | (46%) | XXX | XXX | XXX |
| Net Profit | ($5M) | XXX | ($4M) | XXX | XXX | XXX |
| Net Margin | (50%) | XXX | (40%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
NeuroOne Medical Stock Performance
NeuroOne Medical has current market cap of $37M, and enterprise value of $34M.
Market Cap Evolution
NeuroOne Medical's stock price is $0.74.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $34M | $37M | 2.4% | XXX | XXX | XXX | $-0.07 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialNeuroOne Medical Valuation Multiples
NeuroOne Medical trades at 3.3x EV/Revenue multiple, and (11.3x) EV/EBITDA.
EV / Revenue (LTM)
NeuroOne Medical Financial Valuation Multiples
As of April 11, 2026, NeuroOne Medical has market cap of $37M and EV of $34M.
Equity research analysts estimate NeuroOne Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
NeuroOne Medical has a P/E ratio of (7.3x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $37M | XXX | $37M | XXX | XXX | XXX |
| EV (current) | $34M | XXX | $34M | XXX | XXX | XXX |
| EV/Revenue | 3.3x | XXX | 3.7x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (11.3x) | XXX | XXX | XXX |
| EV/EBIT | (5.8x) | XXX | (8.1x) | XXX | XXX | XXX |
| EV/Gross Profit | 6.0x | XXX | 6.6x | XXX | XXX | XXX |
| P/E | (7.3x) | XXX | (10.4x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (11.7x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified NeuroOne Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
NeuroOne Medical Margins & Growth Rates
NeuroOne Medical's revenue in the last 12 month grew by 29%.
NeuroOne Medical's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.5M for the same period.
NeuroOne Medical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 29% | XXX | 26% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (33%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (69%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.5M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.5M | XXX | XXX | XXX |
| R&D Expenses to Revenue | 53% | XXX | 55% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 103% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
NeuroOne Medical Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| CytoSorbents | XXX | XXX | XXX | XXX | XXX | XXX |
| Pulsenmore | XXX | XXX | XXX | XXX | XXX | XXX |
| Implanet | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivos | XXX | XXX | XXX | XXX | XXX | XXX |
| Mauna Kea Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
NeuroOne Medical M&A Activity
NeuroOne Medical acquired XXX companies to date.
Last acquisition by NeuroOne Medical was on XXXXXXXX, XXXXX. NeuroOne Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by NeuroOne Medical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialNeuroOne Medical Investment Activity
NeuroOne Medical invested in XXX companies to date.
NeuroOne Medical made its latest investment on XXXXXXXX, XXXXX. NeuroOne Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by NeuroOne Medical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout NeuroOne Medical
| When was NeuroOne Medical founded? | NeuroOne Medical was founded in 2009. |
| Where is NeuroOne Medical headquartered? | NeuroOne Medical is headquartered in United States. |
| How many employees does NeuroOne Medical have? | As of today, NeuroOne Medical has over 18 employees. |
| Who is the CEO of NeuroOne Medical? | NeuroOne Medical's CEO is David A. Rosa. |
| Is NeuroOne Medical publicly listed? | Yes, NeuroOne Medical is a public company listed on Nasdaq. |
| What is the stock symbol of NeuroOne Medical? | NeuroOne Medical trades under NMTC ticker. |
| When did NeuroOne Medical go public? | NeuroOne Medical went public in 2012. |
| Who are competitors of NeuroOne Medical? | NeuroOne Medical main competitors are CytoSorbents, Pulsenmore, Implanet, Vivos. |
| What is the current market cap of NeuroOne Medical? | NeuroOne Medical's current market cap is $37M. |
| What is the current revenue of NeuroOne Medical? | NeuroOne Medical's last 12 months revenue is $10M. |
| What is the current revenue growth of NeuroOne Medical? | NeuroOne Medical revenue growth (NTM/LTM) is 29%. |
| What is the current EV/Revenue multiple of NeuroOne Medical? | Current revenue multiple of NeuroOne Medical is 3.3x. |
| Is NeuroOne Medical profitable? | No, NeuroOne Medical is not profitable. |
| What is the current net income of NeuroOne Medical? | NeuroOne Medical's last 12 months net income is ($5M). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.